合作区将重点推动"四新"产业和澳资产业发展 横琴将加强重点产业规模和发展能级来促进澳门经济适度多元发展。 《规划》明确，到2029年澳门回归祖国30周年时，合作区与澳门经济高度协同、规则深度衔接的制度体系全面确立，市场准入制度高效衔接。各类要素跨境 流动高效便捷，电子围网系统和跨境金融管理体系建立健全，货物"一线放开、二线管住"的体系高效运转，人员出入境高度便利。同时，特色产业发展形成 规模，"四新"产业增加值占地区生产总值比重从2024年的59.4%提升至65%。澳资产业增加值从2024年的30.04亿元增加至90亿元。 6月30日，《横琴粤澳深度合作区产业发展规划（2025—2029年）》（下称《规划》）印发，明确了横琴粤澳深度合作区（下称"合作区"）接下来几年时间 里，在重点产业培育、营商环境建设和琴澳产业一体化等方面的发展思路。 "横琴合作区产业发展的前景，跟同澳门展开深度合作有密切关系。"中山大学岭南学院经济学教授林江告诉第一财经，横琴最重要的机遇是通过粤澳深度合 作，来为澳门中小企业提供一个创新升级的机会。 Film B Har Car . I H T = K HU.U. 上海 Tom The F ...

Core Viewpoint - The implementation of the Traditional Chinese Medicine (TCM) Law has significantly advanced the development of TCM in China, with over 1.6 billion TCM treatments recorded in 2024, reflecting its growing importance in the healthcare system [1][3][7] Group 1: Policy and Legal Framework - The TCM Law, enacted on July 1, 2017, serves as a comprehensive legal foundation for the reform and development of TCM, guiding a series of supporting regulations and policies [1][2] - The Chinese government has issued multiple policies to enhance TCM quality and promote its high-quality development, integrating TCM into the broader Healthy China initiative [1][2] Group 2: Achievements in TCM Development - TCM hospitals and clinics have achieved full coverage in cities and communities, with the number of licensed TCM practitioners reaching 971,000 [2] - The quality of TCM products has improved, with the overall pass rate for TCM decoction pieces reaching approximately 97% and the pass rate for proprietary Chinese medicines maintaining above 99% [2] Group 3: Accessibility and Service Expansion - TCM services have become more accessible, with community health centers in Wuhan fully equipped with TCM facilities, leading to a significant increase in TCM treatment volumes [3] - The total number of TCM treatments in 2024 exceeded 1.6 billion, showing a marked increase compared to 2023 [3] Group 4: Innovation and Product Development - Since the reform of the TCM approval system in 2021, 53 new TCM products have been approved, including 25 classic formulations, indicating a boost in innovation [4] - The number of pediatric TCM products has also increased, providing new options for children's medication [4] Group 5: Cultural Integration and Global Outreach - TCM culture is gaining popularity, with traditional health concepts and products becoming widely accepted and integrated into modern lifestyles [5] - Efforts are being made to promote TCM internationally, including collaborations with the World Health Organization and the establishment of international standards for TCM practices [6]

马小丽教授指出："全国名中医继承仲景情志病思想，以半夏厚朴汤、栀子厚朴汤为基础方，拟定八味除烦汤，更适用于青少年、职场人群、老年人群、躯 体共病、发热性疾病患者人群。并且，为更好地造福更多抑郁焦虑患者，在八味除烦汤基础上创新转化研发出解郁除烦胶囊。"她表示，解郁除烦胶囊具有 多通道作用及良好的抗抑郁焦虑效果，且临床安全性更高，可作为新的治疗选择。 随后，马小丽教授在报告中介绍了多项解郁除烦胶囊治疗抑郁症的科学研究。"动物行为学研究显示，解郁除烦胶囊可能通过调节中枢神经中单胺类神经递 质水平NA、DN、5-HT发挥抗抑郁作用。一项随机、双盲、双模拟、多中心，样本量达560例的临床研究结果显示，对于主要证候为气郁痰阻、郁火内扰证 患者，解郁除烦胶囊可显著降低汉密顿焦虑量表（HAMA）评分，改善轻中度抑郁症患者抑郁焦虑状态、缓解躯体症状，且不增加不良反应发生率。解郁 除烦联合多元化有氧运动的临床研究显示，可提升青少年抑郁症整体疗效，减弱抑郁人格倾向、精神病态人格倾向，转变患者疾病应对方式。此外，临床研 究表明，解郁除烦胶囊不良反应发生率与安慰剂相当，明显低于氟西汀，安全性良好。" 近年来，随着中医药传承创新发展，在 ...

智通财经APP获悉，据港交所6月30日披露，北京同仁堂医养投资股份有限公司(简称：同仁堂医养)向港 交所主板递交上市申请，中信证券为其独家保荐人。该公司曾于2024年6月28日及12月31日递表港交 所。 截至2025年6月24日，公司已建立分级医疗服务网络，包括12家自有线下医疗机构及一家互联网医院， 以及10家线下管理医疗机构。公司依托知名品牌"同仁堂"及优质的药品，已积累及整合大量线上线下医 疗资源。 按2024年总门诊人次及住院人次计，公司是中国非公立中医院医疗服务行业中最大的中医院集团，市场 份额为1.7%。按2024年医疗服务总收入计，公司以0.2%的市场份额在非公立中医院医疗服务行业中排 名第二，其市场规模占同年中国中医医疗服务行业市场总规模的46.5%。 公司收入主要来自医疗服务；管理服务；及销售健康产品及其他产品。具体来看，截至2023年度，公司 医疗服务产生的收入约9.95亿元，管理服务产生的收入约960万元，销售健康产品及其他产品产生的收 入约1.38亿元。 作为一家中医医疗集团，公司一直利用其在管理能力及医疗资源方面的优势，通过建立、划转及收购以 发展医疗服务网络。于往绩记录期间已并入 ...

Core Insights - Hong Kong Guangren Tang Pharmaceutical Co., Ltd. has a rich history dating back to 1903, showcasing a commitment to traditional Chinese medicine while embracing innovation [2][10] - The company was founded by Liu Nan Gong, who transitioned from a scholar to a physician in response to the health crises of his time, establishing a legacy of compassionate care [2][3] - The company has evolved from a small clinic to a significant player in the industry, maintaining its core values of quality and community service [6][10] Company History - The establishment of Guangren Tang in 1903 marked a pivotal moment, with Liu Nan Gong dedicating his life to medicine after witnessing the suffering caused by epidemics [2][3] - The initial setup included two consultation rooms and a pharmacy, emphasizing a charitable approach to healthcare by providing free services to the needy [3][4] - Liu Nan Gong's innovative "Three Discrimination Therapy" became well-known for effectively treating various ailments, enhancing his reputation in the community [2][4] Leadership and Development - In 1908, Liu Nan Gong's son, Ji Men, took over the leadership, focusing on preserving and documenting his father's medical practices, resulting in the compilation of "Guangren Tang Medical Treatises" [4][5] - Ji Men established a quality control system for medicinal herbs, ensuring the efficacy of treatments, and developed the "Children's Tranquil Powder," which gained popularity for treating pediatric conditions [5][6] - Under Ji Men’s management, Guangren Tang expanded its operations, producing various traditional Chinese medicines and laying the groundwork for the future establishment of Hong Kong Guangren Tang Pharmaceutical Co., Ltd. in the 1950s [6][10] Modernization and Innovation - The company embraced modernization in the 1970s under the leadership of Liu Mu Xian, incorporating modern pharmaceutical equipment while preserving traditional methods [7][8] - The development of "Guangren Huoluo Pills" became a flagship product, addressing common health issues among office workers and achieving significant market success [8][10] - In the 21st century, the company has focused on integrating traditional practices with modern scientific research, collaborating with universities to validate the efficacy of its products [9][10] Quality Control and Market Expansion - The company has established a comprehensive quality control system, including 12 medicinal herb cultivation bases, ensuring high standards from cultivation to production [9] - Products have gained international recognition, successfully entering European markets after passing stringent regulatory processes [9] - The company actively engages in community service and cultural preservation, contributing 5% of its revenue to traditional Chinese medicine initiatives and establishing scholarships for students in the field [9][10]

Core Points - The Confucius Institute at the University of San Marino, established in collaboration with Beijing City University, focuses on traditional Chinese medicine (TCM) education and cultural exchange, celebrating its 10th anniversary with various activities [1][2] - The institute has expanded its reach by offering Chinese language courses at local educational institutions and organizing cultural workshops, attracting over 1,000 participants annually [2] Group 1: Activities and Impact - A recent TCM experience event was held, where instructors from Beijing City University demonstrated acupuncture techniques and TCM practices to local residents, enhancing community engagement [1] - The institute also hosted an academic seminar on TCM dietary therapy, highlighting the systematic theories and effectiveness of TCM in disease prevention and treatment [1] Group 2: Educational Initiatives - The Confucius Institute has established Chinese language courses recognized for credits at a local university and high school, contributing to the growing interest in Chinese culture and language [2] - Regular workshops on calligraphy and tea art, along with celebrations of traditional Chinese festivals, further promote cultural understanding and participation among the local population [2] Group 3: Future Prospects - The institute aims to continue its collaboration with local educational institutions and TCM organizations to further promote Chinese culture and TCM knowledge in San Marino and Italy [2]

Core Viewpoint - The article highlights the increasing popularity and effectiveness of "Sanfu Ties" (three-volt patches) in traditional Chinese medicine, particularly during the summer months for treating chronic conditions. Group 1: Industry Insights - The annual "Sanfu Ties" treatment is set to begin, with significant patient interest; over 5,000 patients are expected to be served this year by the Capital Medical University Affiliated Beijing Traditional Chinese Medicine Hospital alone [1][5] - The production of "Wen Yang Hua Tan" patches involves a meticulous process, combining six medicinal ingredients, each with unique therapeutic properties [3][4] - The production of these patches adheres to strict national quality management standards, ensuring high-quality medicinal products [4][5] Group 2: Traditional Medicine Practices - "Winter diseases treated in summer" is a distinctive feature of traditional Chinese medicine, leveraging the body's natural energy during summer to treat "yang deficiency cold-type" diseases [5] - The patches work by applying herbal medicine to specific body points, stimulating meridians and allowing for the absorption of medicinal components [5][7] - The integration of modern technology with traditional practices is evident, as the industry evolves to meet contemporary health needs while preserving ancient wisdom [7]

Group 1 - The article highlights the launch of three major summer markets in Shandong: the "Yellow River Market," "Canal Market," and "Marine Market," which will take place simultaneously on June 28, featuring diverse cultural and shopping activities [1][4][15] - The events aim to enhance consumer experiences by integrating local culture and products, creating a vibrant atmosphere for cultural exchange and commercial transactions [3][9] - The markets will include various attractions such as traditional Chinese medicine consultations, non-heritage craft demonstrations, and food festivals, appealing to both locals and tourists [4][11][15] Group 2 - The "Yellow River Market" showcases local products and allows consumers to witness the production process, enhancing trust and engagement with the products [4][6][12] - The "Canal Market" features interactive digital art installations, providing a modern twist to traditional market experiences, thus attracting a younger audience [8][9] - The "Marine Market" emphasizes high-quality seafood and local specialties, meeting consumer expectations for diverse and premium offerings [11][12] Group 3 - Experience-based consumption is emerging as a new trend in market activities, allowing consumers to participate in the creation process and fostering a sense of community [13][15] - The summer markets will utilize a combination of offline immersive experiences and online promotions to maximize reach and engagement, running until late August [15][16] - Government support and financial incentives will be provided to enhance consumer participation and ensure affordability during the events [15]

高质量党建引领高质量发展。 坚持党的领导、加强党的建设，是我国国有企业的光荣传统，是国有企业的"根"和"魂"，是我国国有企业的独特优势。 截至2025年6月，由同仁堂集团、首旅集团、京能集团三家北京市属国企党委率先发起建立的"党建引领产业创新联建机制"（以下简称"党建联建机制"）已 在实践中进行了一年的探索。一年来，党建联建机制秉持"党建引领、资源共享、优势叠加、协同发展"的合作理念，在组织链强化、产业链创新、服务链升 级等方面携手共进、强强联合，取得显著成效。各成员单位以党建联建为引领、以文化传承为纽带、以产业协同为核心，探索出一条党建与经营深度融合、 红色基因与创新动能同频共振的新路径。这一创新实践不仅拓展了老字号企业的价值链，更以"党建链"赋能"产业链"，在新时代经济格局中开辟出传统产业 转型升级的先锋范式。 积力所举无不胜，众智所为无不成。党建联建机制通过打破企业间资源壁垒、激活跨行业创新潜能，为破解党建与生产经营"两张皮"问题探索出了一条行之 有效的新思路、新方法，展示出首都国企在党建引领下的强大韧性和蓬勃活力，将为推动首都经济高质量发展作出更大贡献。 一年的党建联建硕果累累 党建联建机制作为党建创 ...

Core Viewpoint - The company, Guoshengtang, demonstrates strong resilience in performance growth, with a projected revenue increase in the second quarter of 2025 surpassing that of the first quarter due to rapid store expansion and a stable policy environment [1][2]. Group 1: Performance and Growth - In Q1 2025, Guoshengtang's offline patient visits increased by 12.7% year-on-year, showing a month-on-month acceleration trend [1]. - The company plans to open 15-20 new stores in 2025, including self-built and acquired locations, and aims to enter 2-3 new cities [1]. - Guoshengtang's revenue growth in the second half of 2025 is expected to exceed that of the first half due to base effects [1]. Group 2: Technological Advancements - On June 7, 2025, Guoshengtang launched the first national AI digital twin of a traditional Chinese medicine (TCM) expert, Professor Li Hao, which utilizes deep learning from over 40 years of clinical experience [2]. - The company plans to release 20 AI digital twins of renowned doctors in 2025 to enhance overall diagnostic quality and address the shortage of quality TCM resources [2]. - A partnership with Huawei was established in May 2025 to promote AI technology applications in the TCM field [2]. Group 3: Financial Returns and Shareholder Value - In 2024, Guoshengtang returned a total of 420 million yuan to investors through dividends and buybacks, equivalent to 137% of the company's net profit for that year [3]. - As of June 25, 2025, the company has repurchased approximately 85 million HKD worth of shares, representing 1.1% of the total share capital at the beginning of the year [3]. - The company is expected to continue rewarding shareholders through dividends and buybacks due to strong profitability and cash flow [3].